ArticleNature medicine2018
Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
David F McDermott et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled itcites it